CLOSE

Dialog Box

Loading...
Latest news
See all news
27 Feb 2018 at 12:00AM

APNETs is coming to Melbourne



We are excited to announce Melbourne will play host to the 6th annual Asia Pacific Neuroendocrine Tumour Society (APNETS) meeting, November 9-11, 2018. The Conference Program can be found here.

Neuroendocrine Tumours (NETs) are complex in diagnosis, treatment, and overall care, and their incidence is proven to be on the rise. Due to the complexities of NETs in diagnosis and ongoing treatment, they require care from multiple disciplines, including but not limited to surgeons, pathologists, oncologists, endocrinologists, gastroenterologists, nuclear medicine physicians, radiologists, and specialist nurses.

The APNETS scientific program brings together experts from around the world in all disciplines of NET patient care, presenting the most up to date research, clinical trials, guidelines, treatment options and diagnostics. The scientific program will be based on a problem-orientated approach to patient care, reflecting the multidisciplinary nature of this disease. Accordingly, we hope that regardless of the background of attendees, each will find something of direct interest in each session.

Almost half of the global population lives in the Asia Pacific region in the nations that have a wide range of socio-economic development and varying sophistication in healthcare. This opens the way for regional collaboration in clinical trials and research in NET that both address the challenges of managing a rare disease in countries with limited resources and also the ability to recruit large patient numbers in complex studies using the very techniques that will have international relevance.

So please join us in the 'World's Most Liveable City' in November 2018.

We will be revealing lots more in the coming months including the details of the Patient Symposium on November 11th where we will hear from these invited speakers (below). Watch this space...

   

Prof Halfdan Sorbye

Professor and Head of NET and GI section at Department of Oncology, Haukeland University Hospital, Bergen, Norway. He has a major research focus on Gastroenteropancreatic (GEP) Neuroendocrine carcinoma (NEC), Neuroendocrine Tumors (NET) and metastatic colorectal cancer and also 100 peer review publications, 3330 citations. Read more here






Prof James Yao

James Yao, MD, is professor and chairman of gastrointestinal medical oncology at the MD Anderson Cancer Center, Houston, Texas, United States. He was the chair emeritus of the North American Neuroendocrine Tumor Society (NANETS). Read more here

Category: General
Tags: